#1
|
||||
|
||||
"Ñèíäðîì ñèíåãî ïàëüöà"
Êîëëåãè, ïîìîãèòå, ïëèç, ïðèíÿòü ðåøåíèå ïî ëå÷åíèþ ïàöèåíòêè.
Ó íåå, íàñêîëüêî ÿ ïîíèìàþ, «ñèíäðîì ñèíåãî ïàëüöà» íà ñòîïå (ýìáîëèÿ ïàëüöåâîé àðòåðèè) Ýòî æåíùèíà 68 (êàæåòñÿ – êàðòà íà ðàáîòå) ëåò, ïåðåíåñøàÿ ïåðåñàäêó ïî÷êè ïî ïîâîäó ãëîìåðóëîíåôðèòà (äèàáåòà íåò. Äàæå ñåé÷àñ – ñòåðîèäíîãî). Ó ìåíÿ îíà ëå÷èëàñü ïî ïîâîäó èíôèöèðîâàííîé òðîôè÷åñêîé ÿçâû ãîëåíè, êîòîðàÿ êðàéíå äîëãî çàæèâàëà (îêîëî 1 ãîäà) èç-çà ñêëîííîñòè ê ðàíåâîé èíôåêöèè (èììóíîñóïðåññèÿ), íî ñåãîäíÿ íàêîíåö çàæèëà. Ýòà ÿçâà èìåëà íåáîëüøîé èøåìè÷åñêèé êîìïîíåíò – ïðè äóïëåêñíîì ñêàíèðîâàíèè àðòåðèé íèæíèõ êîíå÷íîñòåé áûëè ñòåíîçû äî 60%. Îêîëî 2 íåäåëü íàçàä ó íåå âîçíèêëè áîëè è öèàíîç â 1 ïàëüöå äðóãîé íîãè. Ñåé÷àñ èìååò ìåñòî âûðàæåííûé öèàíîç äèñòàëüíûõ 2/3 ïàëüöà, îêîëî íîãòÿ ôîðìèðóåòñÿ çîíà íåêðîçà êîæè. Ïîñêîëüêó ÿ ÷àñòî âñòðå÷àþñü ñ èøåìè÷åñêèìè íåêðîçàìè êîæè (îáû÷íî íà ôîíå ñàõàðíîãî äèàáåòà, íî èíîãäà è áåç íåãî), ÿ ïîíèìàþ, ÷òî ïî âèäó ýòî – íå îáû÷íûé èøåìè÷åñêèé íåêðîç íà ôîíå êðèòè÷åñêîé èøåìèè êîíå÷íîñòè, à èìåííî ëîêàëüíûå èøåìè÷åñêèå èçìåíåíèÿ. Íà 5-õ ïàëüöàõ îáåèõ ñòîï – òîæå öèàíîç êîæè, ïðè ýòîì – áåç áîëåé è íåêðîçîâ. Âîò ôîòîãðàôèè (ê ñîæàëåíèþ, ñíèìàë òåëåôîíîì, ïîëó÷èëîñü òàê ñåáå). [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Ïî ïîâîäó íåêðîçà êîæè ÿ ïðîâîæó ëå÷åíèå, êàê ïðè äèàáåòè÷åñêèõ ÿçâàõ (ìåñòíî – àíòèñåïòè÷åñêèå ìàçè, ïåðåâÿçî÷íûé ìàòåðèàë «Èíàäèí», ðàçãðóçî÷íûé «ïîëóáàøìàê», àíòèáèîòèêè).  êà÷åñòâå àíòèàãðåãàíòîâ ïàöèåíòêà ïîëó÷àåò òèêëîïèäèí 250 õ 2ð, åùå åé íàçíà÷èëè ïåíòîêñèôèëëèí (ÿ íå ñòàë îòìåíÿòü). Íà ôîíå ïðèåìà ãëþêîêîðòèêîèäîâ (êîìïîíåíò èììóíîñóïðåññèè) ó íåå óæå ïîâûøåí ðèñê æåëóäî÷íîãî êðîâîòå÷åíèÿ (ïîëó÷àåò îìåç) + âðåìÿ ñâåðòûâàíèÿ êðîâè ñëåãêà ïðåâûøàåò íîðìó (êîíåö ñâåðò. – 6 ìèí ïðè íîðìå äî 5). Ïîýòîìó íå õî÷åòñÿ íàçíà÷àòü àíòèêîàãóëÿíòû áåç ÿâíûõ íà òî îñíîâàíèé.  ñâÿçè ñ ýòèì – õî÷ó óçíàòü ìíåíèå êîëëåã ïî âîïðîñàì: 1. Åñòü ëè êàêèå-òî Guidelines ïî ýòîìó (ðåäêîìó) ñîñòîÿíèþ, è äëÿ ÷åãî äîêàçàí ýôôåêò? 2. Äîêàçàí ëè ýôôåêò íèçêîìîëåêóëÿðíûõ ãåïàðèíîâ? È â êàêîé äîçå èõ çäåñü ïðèìåíÿòü, íàñêîëüêî âåëèê ðèñê ÏÝ? 3. Ìîæåò áûòü, ìîæíî åå êóäà-òî íàïðàâèòü, ãäå ñ ýòîé ïðîáëåìîé áëèçêî çíàêîìû??? Îòíîñèòåëüíî íåäàâíî ÿ èìåë îïûò ëå÷åíèÿ ïîäîáíîé ïðîáëåìû ó æåíùèíû ñ ñàõàðíûì äèàáåòîì. Òîæå âûðàæåííûé öèàíîç ïàëüöà, êîòîðûé ñ òå÷åíèåì âðåìåíè è íà ôîíå òåðàïèè àíòèàãðåãàíòàìè + âàçàïðîñòàí áëåäíåë è óìåíüøàëñÿ ïî ïëîùàäè. Íî â òîò ïåðèîä, êîãäà öèàíîç áûë âûðàæåííûé, ñôîðìèðîâàëñÿ íåáîëüøîé íåêðîç êîæè (òîæå îêîëî íîãòÿ), êîòîðûé çàæèâàë îêîëî 7-8 ìåñ. Åñëè êîìó èíòåðåñíî – ìîãó âûëîæèòü ôîòî ïî ñòàäèÿì. |
#2
|
|||
|
|||
ß íå õèðóðã. Óìíè÷àòü íå áóäó. Íî ëèòåðàòóðîé ïîäåëèòüñÿ ìîãó. Ìîæåò ÷òî-òî ïîëåçíîå òàì íàéäåòå.
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |
#3
|
|||
|
|||
Öèòàòà:
Ñàìîå ñâåæåå èç òîãî ÷òî åñòü ðåëåâàíòíî: Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |
#4
|
|||
|
|||
÷òî êðåàòèíèí, ôîñôîð, êàëüöèé. ÷òî ãåìîãëîáèí. ÖÐÁ, àëüáóìèí. ×òî ëèïèäû, ÷òî äàâëåíèå. ÷òî Éåé-Áè-Àé. ÷òî äîçà ïðîãðàôà/ÖÍÈ, ÷òî- óðîâåíü.
ß íå èñêëþ÷àþ, ÷òî äåëà ñ òðàíñïëàíòàòîì íå îñîáî õîðîøè. |
#5
|
||||
|
||||
Îòòîðæåíèå òðàíñïëàíòàòà èëè íàðóøåíèå åãî ôóíêöèîíèðîâàíèÿ ìîæåò âûçûâàòü ïðîáëåìû ñ êðîâîñíàáæåíèåì ïàëüöåâ?
|
#6
|
|||
|
|||
Aortoiliac Occlusive Disease
The distal abdominal aorta and the iliac arteries are common sites of involvement with atherosclerosis. Aortoiliac occlusive disease occurs in a relatively younger group of patients (aged in their mid-50s), compared with patients with more femoropopliteal disease. It also differs from disease of the femoral-popliteal-tibial segment since it is rarely limb-threatening. Symptoms typically consist of bilateral thigh or buttock claudication and fatigue. Men report diminished penile tumescence, and there may later be complete failure of erectile function. These symptoms constitute Leriche's syndrome. Rest pain is unusual with isolated aortoiliac disease. Femoral pulses are usually diminished or absent. There are usually no stigmata of ischemia unless distal disease coexists. 99–102 A small group of patients report a prolonged history of thigh and buttock claudication that has recently become more severe. It is likely that this group has underlying significant aortoiliac disease that has suddenly progressed to acute occlusion of the terminal aorta. Others may present with "trash foot," representing microembolization into the distal vascular bed (Fig. 22-68). [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Noninvasive tests such as pulse volume recordings of the lower extremity with estimation or the thigh-brachial pressure index may be suggestive of aortoiliac disease. Definitive diagnosis, however, can only be established by arteriography. This further provides important information regarding distal arterial run-off (particularly the profunda femoris) and demonstrates pelvic collaterals that may be important in maintaining lower limb viability. It must be emphasized, however, that patients should be subjected to angiography only if their symptoms warrant surgical intervention. Schwartz's Surgery > Part II. Specific Considerations > Chapter 22. Arterial Disease > À êàê íà ñ÷åò ýòîãî? |
#7
|
||||
|
||||
À ÷òî íàñ÷åò íèçêîìîëåêóëÿðíûõ ãåïàðèíîâ? Åñòü ëè ó ïàöèåíòêè ÕÏÍ è åñëè åñòü, íàñêîëüêî îíà âûðàæåíà?
|
|
#8
|
|||
|
|||
CKD- ñåðü¸çíûé ôàêòîð ðèñêà ïðîãðåññèðîâàíèÿ àòåðîñêëåðîçà. Ïàëåö åòîò,ñêîðåå âñåãî, åñëè è íå ïîïðàâèòñÿ, òî åå íå óáü¸ò. À âîò åñëè òàì êëóáî÷êîâàÿ ôèëüòðàöèÿ 10, òî åòî äëÿ äîëãîñðî÷íîãî ïðîãíîçà,è äëÿ îïðåäåëåíèÿ ðèñêà äëÿ ïðî÷èõ ïàëüöåâ/ îðãàíîâ âàæíàÿ èíôîðìàöèÿ. Âî âñÿêîì ñëó÷àå, èìõî,áîëåå âàæíûé âîïðîñ ïî î÷åðåäíîñòè ÷åì âîïðîñ î ïåíòîêñèôèëëèíå è ìåñòíîì ëå÷åíèè.
...æåíøèíà ñóäÿ ïî âñåìó ïîòåðÿëà ìíîãî ìûøå÷íîé ìàññû, êðåàòèíèí äàæå ïðè âûðàæåííîé óðåìèè ìîæåò áûòü íå îñîáî âïå÷àòëÿþøèì. Ïðîñòî âûãëÿäèò åòî âñå êàê îäíà èç çàïóøåííûõ íàøèõ áîëüíûõ- ôîñôîð 2, àëüáóìèí 30, ãåìîãëîáèí 90 è ò.ä. |
#9
|
||||
|
||||
Êîëëåãè, âñåì áîëüøîå ñïàñèáî,
÷àñòü äàííûõ â êàðòå ïàöèåíòêè íà ðàáîòå (ÿ ñåé÷àñ íå òàì), ÷àñòü - ó íåå íà ðóêàõ. Ñêîðî äîáåðóñü äî ýòèõ äàííûõ, âûëîæó ïîïîäðîáíåå... |
#10
|
||||
|
||||
Öèòàòà:
Íî íèêòî íå ïèøåò, êàê ëå÷èòü Âîçìîæíî, èç-çà îòíîñèòåëüíîé ðåäêîñòè ýòîãî ñîñòîÿíèÿ ìàëî ðàçðàáîòàíî EBM-ìåòîäîâ ëå÷åíèÿ... Öèòàòà:
À çäåñü - íåñêîëüêî ïîâûøåí ðèñê êðîâîòå÷åíèé (ÂÑÊ óäëèíåíî, äîëãî ïðèíèìàåò ãëþêîêîðòèêîèäû âíóòðü, õîòÿ è ïðèêðûâàÿñü îìåçîì)... Ïîýòîìó ÿ êàê áû èùó äîêàçàòåëüñòâà ïîëüçû ÍÌà â äàííîé ñèòóàöèè, ÷òîáû íå çðÿ ðèñêîâàòü... Îïÿòü æå, íåÿñíî, â êàêîé äîçå íàçíà÷àòü - ïðîôèëàêòè÷åñêîé (ò.å., ìèíèìàëüíîé) èëè ëå÷åáíîé (êàê ïðè îñòðîì êîðîíàðíîì ñèíäðîìå?) |
#11
|
|||
|
|||
À êàêàÿ èììóíîñóïðåññèÿ?
Íåò ïîäîçðåíèÿ íà drug-induced? |
#12
|
||||
|
||||
Íàçíà÷àòü íàäî â ëå÷åáíîé äîçå, íî 1 ðàç â äåíü èç-çà ÕÏÍ. ÂÑÊ ïîêàçàòåëü äîñòàòî÷íî ìóòíûé... Ëó÷øå ìåðÿé àíòè-Õà àêòèâíîñòü
|
#13
|
||||
|
||||
|
#14
|
|||
|
|||
Îëåã, ÿ â Òîðîíòî.
...åñëè è ïðàâäà êðåàòèíèí ñòîéêî 120, òî äåëà íåïëîõè. ×òî âñå-òàêè ñ êàëüöèåì, ôîñôîðîì, ÏÒÃ(åñëè åñòü) è óðîâíåì ïðîãðàôà/öèêëîñïîðèíà... |
#15
|
||||
|
||||
Íàñ÷åò ýâèäåíñîâ íå óâåðåí
|